Hung KC, Chao CT. Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis. J Am Soc Nephrol 2024 May 20. doi: 10.1681/ASN.0000000000000385.
PMID: 38767962